Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

August 5, 2008 | Customer News

Tecan’s Infinite® M1000 and Infinite F500 multimode readers are granted LanthaScreen™ Certified Plus status by Invitrogen Corporation


Tecan, a global leader in laboratory automation and detection, has been granted LanthaScreen™ Certified Plus status for selected Infinite® multimode readers, by Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics. The certification is only given to microplate readers that meet high-level criteria for instrument set-up and performance with the LanthaScreen™ TR-FRET assay technology, and reflects the outstanding sensitivity and speed of the Infinite M1000 and Infinite F500 multimode microplate readers.


The Infinite M1000, the first monochromator-based instrument to receive LanthaScreen™ Certified Plus status, is Tecan’s new, high-end, premium quad4 monochromators™-based multimode instrument, providing outstanding flexibility, sensitivity and speed for demanding applications in drug discovery, life sciences and research.

The Infinite F500, Tecan’s high-end, filter-based multimode instrument, offers significantly improved performance for TR-FRET based measurements. The optional integration of reagent injectors (two injectors with selectable volumes), the optional 1,536-well reading capability, as well as ultra-lightweight programmable filter slides and automated z-focusing in all top reading modes, make this a powerful and versatile drug discovery tool in assay development and screening.

As part of a recent collaborative agreement, several Invitrogen drug discovery products have been validated by Invitrogen on the Infinite M1000 and Infinite F500 microplate readers, including GeneBLAzer®, LanthaScreen™, Adapta™ Universal Kinase Assay, Z’-LYTE®, Omnia® and PolarScreen™.

LanthaScreen, Adapta and PolarScreen are trademarks of Invitrogen Corporation, GeneBLAzer, Omnia and Z’-LYTE are registered trademarks of Invitrogen Corporation.

About Tecan

Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).

For further information please contact:

Tecan Group Ltd.
Cornelia Kegele
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12